激光间质热疗治疗内侧颞叶癫痫
基于前瞻性多中心注册研究LAANTERN,纳入145例药物难治性内侧颞叶癫痫患者接受激光间质热疗,77例完成2年随访。2年Engel 1级和ILAE 1/2级分别达58.4%和57.2%,不良事件16.5%且多为轻度短暂,约三分之一患者减少或停用抗癫痫药物,生活质量多数时间点改善。
要点
- LITT治疗药物难治性MTLE的2年Engel 1级为58.4%。
- 不良事件发生率16.5%,多为轻度短暂。
- 约三分之一患者术后减少或停用抗癫痫药物。
核心结论
- LITT治疗药物难治性MTLE耐受性良好,癫痫控制和生活质量改善具有临床意义,可考虑作为治疗选择。
研究设计与样本
- LAANTERN为前瞻性多中心注册研究,2015年10月至2023年3月在美国15个四级癫痫中心纳入145例药物难治性MTLE患者,其中77例完成2年随访。
主要发现
- 2年Engel 1级为45/77(58.4%),ILAE 1/2级为44/77(57.2%)。
- 不良事件见于24例(16.5%),多为轻度短暂。
- 约三分之一患者减少或停用抗癫痫药物,生活质量评分在几乎所有评估时间点改善。
- 儿童患者癫痫结局与成人相似。
关键数值与推荐
- 平均(SD)消融体积28.2(29.8)mL,平均手术时长4.3(2.1)小时,平均失血量22(17.6)mL。
- 住院时间中位数1(1-3)天,33例(23%)术后未入ICU,ICU时间中位数22(19.2-28.8)小时。
- 出院时头痛评分平均2.1(2.6)(0-10分),140例(96.6%)出院回家。
临床怎么用
- 对于药物难治性MTLE,LITT可作为外科治疗选项之一,需结合患者个体情况评估。
局限性
- 原文未报告无对照组比较,部分患者随访不足2年(仅77/145完成2年随访)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Laser interstitial thermal therapy (LITT) is a surgical tool used to ablate epileptic foci and brain tumors. Understanding clinical and procedural outcomes of LITT for mesial temporal lobe epilepsy (MTLE) is relevant to clinicians and patients. OBJECTIVE: To describe seizure outcomes, procedural outcomes, and safety data of MTLE LITT. DESIGN, SETTING, AND PARTICIPANTS: Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) is a prospective multicenter registry with up to 5 years of follow-up lasting from October 2015 to March 2023 at LAANTERN epilepsy sites, which are all level IV National Association of Epilepsy Centers in the US. Adult and pediatric LAANTERN enrollees undergoing LITT for drug-resistant MTLE with at least 6 months of follow-up were included. Those with epilepsy related to a malignant lesion were excluded. INTERVENTION: LITT for drug-resistant MTLE. MAIN OUTCOMES AND MEASURES: Demographic, epilepsy, and seizure characteristics; procedural data; postsurgical seizure outcomes; safety data; and quality of life (QOL) scores were prospectively collected. RESULTS: Fifteen centers enrolled 145 patients (73 [50.3%] female) with MTLE undergoing LITT, with 77 reaching 2-year follow-up. The mean (SD) age was 39.2 (15.4) years at time of LITT with 14 of 145 in the pediatric range (younger than 22 years). The 2 most common etiologies were mesial temporal sclerosis (n = 74) and unknown etiology or magnetic resonance imaging normal (n = 31). Mean (SD) ablation volume was 28.2 (29.8) mL. Mean (SD) surgery duration was 4.3 (2.1) hours, and mean (SD) blood loss was 22 (17.6) mL. Median (IQR) length of stay was 1 (1-3) day, and 33 patients (23%) had no intensive care unit stay postprocedure. Median (IQR) intensive care unit time was 22 (19.2-28.8) hours. Mean (SD) discharge head pain score was 2.1 (2.6) on a 0-10 scale. Most patients (n = 140 [96.6%]) were discharged home. Two-year seizure outcomes were 45 of 77 (58.4%) and 44 of 77 (57.2%) for Engel 1 and International League Against Epilepsy 1/2, respectively. No clinical characteristics were associated with seizure outcome. Adverse events were seen in 24 patients (16.5%), most being mild and transient. Pediatric seizure outcomes were similar to adult outcomes. One-third of patients stopped or decreased their antiseizure medicines. Improvements in QOL scores were seen at almost all time points assessed. CONCLUSIONS: In the largest prospective multicenter MTLE LITT cohort, LITT was found to be well tolerated with clinically meaningful seizure outcomes and QOL improvements. These findings indicate that LITT may be considered as a treatment option for drug-resistant MTLE.
引用
- Landazuri P, Cheng JJ, Leuthardt E, et al. Interstitial Thermal Therapy in Mesial Temporal Lobe Epilepsy. JAMA Neurol. 2025. PMID: 40622685. doi:10.1001/jamaneurol.2025.1897
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。